Cargando…
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
Acute myeloid leukemia (AML) is a heterogeneous disease linked to a broad spectrum of molecular alterations, and as such, long-term disease control requires multiple therapeutic approaches. Driven largely by an improved understanding and targeting of these molecular aberrations, AML treatment has ra...
Autores principales: | Daver, Naval, Alotaibi, Ahmad S., Bücklein, Veit, Subklewe, Marion |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257483/ https://www.ncbi.nlm.nih.gov/pubmed/33953290 http://dx.doi.org/10.1038/s41375-021-01253-x |
Ejemplares similares
-
Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018) -
Next-generation dendritic cells for immunotherapy of acute myeloid leukemia
por: Schnorfeil, Frauke, et al.
Publicado: (2014) -
Recent developments in immunotherapy of acute myeloid leukemia
por: Lichtenegger, Felix S., et al.
Publicado: (2017) -
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
por: Samra, Bachar, et al.
Publicado: (2020) -
Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021)